Book section · January 1, 2015
There has been a remarkable improvement in the survival of patients with chronic myeloid leukaemia (CML) in chronic phase since the introduction of tyrosine kinase inhibitors (TKIs). However there are a significant proportion of patients with CML who are r ...
Full textCite
